Daybreak Partners

About Daybreak Partners

This author has not yet filled in any details.
So far Daybreak Partners has created 8 blog entries.
23 Jul 2020

Arcturus Therapeutics Announces Agreement with Israeli Ministry of Health to Supply COVID-19 Vaccine Candidate, LUNAR-COV19

2020-08-18T15:53:41+00:00

Arcturus Therapeutics Announces Agreement with Israeli Ministry of Health to Supply COVID-19 Vaccine Candidate, LUNAR-COV19

Congratulations to the team at Arcturus Therapeutics on this Agreement with the Israeli Ministry of Health to supply a COVID vaccine

Full Story Here

Arcturus Therapeutics Announces Agreement with Israeli Ministry of Health to Supply COVID-19 Vaccine Candidate, LUNAR-COV192020-08-18T15:53:41+00:00
21 Jul 2020

Arcturus Therapeutics & Duke-NUS Received Approval to Proceed with Phase 1/2 Clinical Trial for COVID-19 Vaccine Candidate, LUNAR-COV19

2020-08-18T15:54:07+00:00

Arcturus Therapeutics & Duke-NUS Received Approval to Proceed with Phase 1/2 Clinical Trial for COVID-19 Vaccine Candidate, LUNAR-COV19

Congratulation to the teams at Daybreak Partners portfolio company Arcturus Therapeutics and DukeNUS on their receipt of approval from the Singapore HSA to proceed with Phase 1 /2 Clinical Trial for a COVID vaccine!

Full Story Here

Arcturus Therapeutics & Duke-NUS Received Approval to Proceed with Phase 1/2 Clinical Trial for COVID-19 Vaccine Candidate, LUNAR-COV192020-08-18T15:54:07+00:00
3 Jul 2020

Daybreak Announces New Investment in mmhmm

2020-08-18T15:53:12+00:00

Daybreak Announces New Investment in mmhmm

Very excited to announce our most recent investment – in mmhmm, a Personal Video Presence enabler. Check it out, watch the video – and GRAB AN INVITE!

https://www.mmhmm.app

Daybreak Announces New Investment in mmhmm2020-08-18T15:53:12+00:00
10 Jun 2020

Daybreak Announces Financing Round for binah.ai

2020-08-18T15:54:43+00:00

Daybreak Announces Financing Round for binah.ai

Daybreak Partners is very pleased to participate in this financing round for portfolio company binah.ai!

Full Story Here

Daybreak Announces Financing Round for binah.ai2020-08-18T15:54:43+00:00
13 May 2020

iCAD Presents Positive New Clinical Data for Xoft Brain IORT at American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program

2020-08-18T15:55:05+00:00

iCAD Presents Positive New Clinical Data for Xoft Brain IORT at American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program

Portfolio company iCAD Presents Positive New Clinical Data for Xoft Brain IORT at American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program

Full Story Here

iCAD Presents Positive New Clinical Data for Xoft Brain IORT at American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program2020-08-18T15:55:05+00:00
21 Apr 2020

Daybreak Announces Financing Round for MyndYou

2020-08-18T15:55:26+00:00

Daybreak Announces Financing Round for MyndYou

Daybreak Partners is very pleased to participate in this financing round for portfolio company MyndYou

Full Story Here

Daybreak Announces Financing Round for MyndYou2020-08-18T15:55:26+00:00
16 Dec 2019

Daybreak Announces New Investment in Rune Labs

2020-08-18T15:55:49+00:00

Daybreak Announces New Investment in Rune Labs

Very excited to announce our most recent investment – in Rune Labs. Here is a podcast with the founder Brian Pepin produced by co-investor Loop Ventures

Full Story Here

Daybreak Announces New Investment in Rune Labs2020-08-18T15:55:49+00:00
6 Aug 2019

The CF Foundation Awards Arcturus Therapeutics Up to $15M for RNA Therapy

2020-08-18T15:56:15+00:00

The CF Foundation Awards Arcturus Therapeutics Up to $15M for RNA Therapy

Important partnership for our most recent investment (Arcturus Therapeutics) with the Cystic Fibrosis Foundation

Full Story Here

The CF Foundation Awards Arcturus Therapeutics Up to $15M for RNA Therapy2020-08-18T15:56:15+00:00
© Copyright Daybreak Partners   |   All Rights Reserved
LinkedIn
Go to Top